INTERNATIONAL BIOTECHNOLOGY TRUST PLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 166 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,376,040
-31.0%
62,200
-34.9%
0.80%
-23.7%
Q2 2023$3,443,730
+98.3%
95,500
+109.9%
1.05%
+116.1%
Q1 2023$1,736,735
-53.7%
45,500
-44.9%
0.48%
-51.1%
Q2 2021$3,752,000
+159.8%
82,633
+138.6%
0.99%
+159.4%
Q1 2021$1,444,000
-89.0%
34,633
-88.7%
0.38%
-89.4%
Q4 2020$13,136,000
+62.7%
307,6330.0%3.59%
+37.6%
Q3 2020$8,075,000
+1.7%
307,6330.0%2.61%
-1.2%
Q2 2020$7,940,000
+43.6%
307,6330.0%2.64%
+4.7%
Q1 2020$5,531,000
+1.4%
307,6330.0%2.52%
+28.3%
Q4 2019$5,454,000
+568.4%
307,633
+484.5%
1.96%
+421.2%
Q3 2019$816,000
-90.0%
52,633
-88.9%
0.38%
-87.5%
Q2 2019$8,162,000
+6.6%
475,6330.0%3.03%
+7.0%
Q1 2019$7,658,000
+67.2%
475,633
+19.3%
2.83%
-0.5%
Q4 2018$4,579,000
-23.3%
398,633
-7.0%
2.84%
+0.2%
Q3 2018$5,969,000
-17.4%
428,6330.0%2.84%
+2.2%
Q2 2018$7,227,000
+2.9%
428,633
+19.5%
2.78%
+1.2%
Q1 2018$7,026,000
+22.8%
358,633
+26.9%
2.74%
+35.8%
Q4 2017$5,723,000
+16.6%
282,6330.0%2.02%
+5.7%
Q3 2017$4,907,000
+87.2%
282,633
+38.1%
1.91%
+91.8%
Q2 2017$2,621,000
-43.5%
204,633
-42.8%
1.00%
-43.9%
Q1 2017$4,636,000
+710.5%
358,000
+517.2%
1.78%
+588.0%
Q4 2016$572,00058,0000.26%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders